Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gamal Shiha

Showing results (31-40 of 77) with videos related to

Pageof 8
Sort By:
Hepatology International|December 24, 2015
Non-invasive assessment of portal hypertension and liver fibrosis using contrast-enhanced ultrasonographyHitoshi Maruyama, Gamal Shiha, Osamu Yokosuka, et al.
Biomed Research International|April 15, 2021
The Potential Safe Antifibrotic Effect of Stem Cell Conditioned Medium and Nilotinib Combined Therapy by Selective Elimination of Rat Activated HSCsAhmed Nabil, Koichiro Uto, Faten Zahran, et al.
BMC Public Health|June 23, 2021
Usability and acceptability of self-testing for hepatitis C virus infection among the general population in the Nile Delta region of EgyptElena Ivanova Reipold, Ahmed Farahat, Amira Elbeeh, et al.
Tissue & Cell|February 13, 2018
Effect of human umbilical cord blood derived CD34<sup>+</sup> hematopoietic stem cell on the expression of Wnt4 and P53 genes in a rat model of hepatocellular carcinomaRania Naiem Sherif, Hussein Abdellatif, Noha Hazem, et al.
International Urology and Nephrology|October 28, 2020
The effect of anemia on the efficacy and safety of treating chronic hepatitis C infection with direct-acting antivirals in patients with chronic kidney diseaseAhmed Yahia Elmowafy, Mohamed Hamed Abbas, Ahmed Abdelfattah Denewar, et al.
RSC Advances|November 29, 2024
Anti-hepatocellular carcinoma activities of novel hydrazone derivatives <i>via</i> downregulation of interleukin-6Ahmed Nabil, Marwa Abdel-Motaal, Ayman Hassan, et al.
Therapeutic Advances in Gastroenterology|September 2, 2016
The role of antioxidants and zinc in minimal hepatic encephalopathy: a randomized trialNasser Mousa, Ahmed Abdel-Razik, Ashraf Zaher, et al.
European Journal of Gastroenterology & Hepatology|September 11, 2023
Multicenter validation of FIB-6 as a novel machine learning non-invasive score to rule out liver cirrhosis in biopsy-proven MAFLDAmir Anushiravani, Khalid Alswat, George N Dalekos, et al.
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|March 14, 2024
Validation of FIB-6 score in assessment of liver fibrosis in chronic hepatitis BKhalid Alswat, Riham Soliman, Nabiel N H Mikhail, et al.
Alimentary Pharmacology & Therapeutics|September 23, 2024
Individualized HCC surveillance using risk stratification scores in advanced fibrosis and cirrhotic HCV patients who achieved SVR: Prospective studyGamal Shiha, Ayman Hassan, Nasser Mousa, et al.
Pageof 8

Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
Hepatology International|December 24, 2015
Non-invasive assessment of portal hypertension and liver fibrosis using contrast-enhanced ultrasonographyHitoshi Maruyama, Gamal Shiha, Osamu Yokosuka, et al.
Biomed Research International|April 15, 2021
The Potential Safe Antifibrotic Effect of Stem Cell Conditioned Medium and Nilotinib Combined Therapy by Selective Elimination of Rat Activated HSCsAhmed Nabil, Koichiro Uto, Faten Zahran, et al.
BMC Public Health|June 23, 2021
Usability and acceptability of self-testing for hepatitis C virus infection among the general population in the Nile Delta region of EgyptElena Ivanova Reipold, Ahmed Farahat, Amira Elbeeh, et al.
Tissue & Cell|February 13, 2018
Effect of human umbilical cord blood derived CD34<sup>+</sup> hematopoietic stem cell on the expression of Wnt4 and P53 genes in a rat model of hepatocellular carcinomaRania Naiem Sherif, Hussein Abdellatif, Noha Hazem, et al.
International Urology and Nephrology|October 28, 2020
The effect of anemia on the efficacy and safety of treating chronic hepatitis C infection with direct-acting antivirals in patients with chronic kidney diseaseAhmed Yahia Elmowafy, Mohamed Hamed Abbas, Ahmed Abdelfattah Denewar, et al.
RSC Advances|November 29, 2024
Anti-hepatocellular carcinoma activities of novel hydrazone derivatives <i>via</i> downregulation of interleukin-6Ahmed Nabil, Marwa Abdel-Motaal, Ayman Hassan, et al.
Therapeutic Advances in Gastroenterology|September 2, 2016
The role of antioxidants and zinc in minimal hepatic encephalopathy: a randomized trialNasser Mousa, Ahmed Abdel-Razik, Ashraf Zaher, et al.
European Journal of Gastroenterology & Hepatology|September 11, 2023
Multicenter validation of FIB-6 as a novel machine learning non-invasive score to rule out liver cirrhosis in biopsy-proven MAFLDAmir Anushiravani, Khalid Alswat, George N Dalekos, et al.
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|March 14, 2024
Validation of FIB-6 score in assessment of liver fibrosis in chronic hepatitis BKhalid Alswat, Riham Soliman, Nabiel N H Mikhail, et al.
Alimentary Pharmacology & Therapeutics|September 23, 2024
Individualized HCC surveillance using risk stratification scores in advanced fibrosis and cirrhotic HCV patients who achieved SVR: Prospective studyGamal Shiha, Ayman Hassan, Nasser Mousa, et al.
Pageof 8